about
sameAs
Uncommon cause of recurrent infectionsCan mutations in ELA2, neutrophil elastase expression or differential cell toxicity explain sulphasalazine-induced agranulocytosis?Neutrophil elastase mutations in congenital neutropeniaGranulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis.Approach to febrile neutropenia in the general paediatric setting.Severe congenital neutropenia: genetics and pathogenesis.Neutrophil elastase in cyclic and severe congenital neutropenia.Src family kinases are important negative regulators of G-CSF-dependent granulopoiesisThe incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapyThe role of cathelicidin and defensins in pulmonary inflammatory diseases.Allogeneic Transplant in ELANE and MEFV Mutation Positive Severe Cyclic Neutropenia: Review of Prognostic Factors for Secondary Severe Events.Congenital and acquired neutropenia consensus guidelines on diagnosis from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica).Severe congenital neutropenia, a genetically heterogeneous disease group with an increased risk of AML/MDS.Lymphoid enhancer factor-1 links two hereditary leukemia syndromes through core-binding factor alpha regulation of ELA2.The Effect of Bone Marrow Mesenchymal Stem Cells on the Granulocytic Differentiation of HL-60 Cells.Essential role for cyclin D3 in granulocyte colony-stimulating factor-driven expansion of neutrophil granulocytesp38 MAP kinase inhibits neutrophil development through phosphorylation of C/EBPalpha on serine 21.Congenital and acquired neutropenias consensus guidelines on therapy and follow-up in childhood from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica).Long-term follow-up of granulocyte colony-stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy.
P2860
Q24596575-354850C9-1455-493E-99AA-F199913DC612Q24804072-9B30D17E-6AF3-4848-9D19-129286DE8A93Q28203932-29B280B7-FD98-4821-BE9C-94890D8AC1F9Q33780538-CFB0961C-16A0-49DA-A7F2-896F33F2520BQ34600831-56C0F638-CC4C-47F5-84E2-2CBF26351CADQ34767281-1682C86A-9607-4397-B3B6-641962B85007Q35642863-56914D8E-AA73-4F3D-914D-20B0EF777FFDQ35849188-3A0FC184-8EA4-4405-8741-AC17E414E0DFQ35849723-6C5B7D38-97AA-4529-A6DD-5BF199AADC50Q36922272-625A0D9C-93A7-4277-915A-A548718FBD6EQ37618366-7CCC901F-D7FA-4A4B-8D4C-C7AC1B515419Q37859344-02ED8E69-4A8A-461B-9212-7562A6D746BEQ37952706-160520F3-24F1-4B6A-B554-F0960EE7A99DQ38519020-0D43471B-E37E-4184-BC02-F2CC78B20144Q38700425-017BBE0C-A71D-4FF3-8C2D-BC0E88954A6DQ39125900-F4D917CD-0BF3-474B-9C8E-6E87CFAAD864Q45959301-37AA2C7D-745C-4298-9746-6DB53FB9418CQ46478431-CB1D6258-0A37-4389-978C-2E54B411FF26Q54789394-D86EE34C-AB90-4CAE-BD60-3D98E37A53BC
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Kostmann syndrome and severe congenital neutropenia
@ast
Kostmann syndrome and severe congenital neutropenia
@en
Kostmann syndrome and severe congenital neutropenia
@nl
type
label
Kostmann syndrome and severe congenital neutropenia
@ast
Kostmann syndrome and severe congenital neutropenia
@en
Kostmann syndrome and severe congenital neutropenia
@nl
prefLabel
Kostmann syndrome and severe congenital neutropenia
@ast
Kostmann syndrome and severe congenital neutropenia
@en
Kostmann syndrome and severe congenital neutropenia
@nl
P356
P1476
Kostmann syndrome and severe congenital neutropenia
@en
P2093
Cornelia Zeidler
Karl Welte
P356
10.1053/SHEM.2002.31913
P407
P577
2002-04-01T00:00:00Z